Ultrasensitive cross-species measurement of cardiac troponin-I using the erenna immunoassay system

Toxicologic Pathology

Volumn 36, Issue 6, 2008, Pages 777-782

  Schultze, A Eric ^a   Konrad, Robert J ^a   Credille, Kelly M ^a   Lu, Quynh Anh ^b   Todd, John ^b  

^a ELI LILLY AND COMPANY   (United States)

^b SINGULEX INC   (United States)

Author keywords

Cardiac troponin; Cardiotoxicity; cTnI; Dog; Human; Monkey; Rat

Indexed keywords

CARDIAC TROPONIN I; ISOPRENALINE; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOG; FEMALE; HEART INJURY; HISTOPATHOLOGY; IMMUNOASSAY; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; DOGS; FEMALE; HEART DISEASES; HUMANS; IMMUNOASSAY; ISOPROTERENOL; LINEAR MODELS; MACACA FASCICULARIS; MALE; MYOCARDIUM; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TROPONIN I;

ANIMALIA; CANIS FAMILIARIS; ERENNA; RATTUS;

EID: 54949117119     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623308322016     Document Type: Article

References (21)

1. Adin, DB, MA Oyama, MM Sleeper, and RJ Milner (2006). Comparison of canine cardiac troponin I concentrations as determined by 3 analyzers. J Vet Intern Med, 20, 1136-42.
2. Anversa, P, J Kajstura, A Leri, and R Bolli (2006). Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation, 113, 1451-63.
3. Anversa, P, A Leri, M Rota, T Hosoda, C Bearzi, K Urbanek, J Kajstura, and R Bolli (2007). Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells, 25, 589-601.
4. Apple, FS, MM Murakami, R Ler, D Walker, and M York (2005). Cardiac troponin I and T immunoassay response to cardiac troponin release from experimentally induced damage to rat, dog and monkey hearts. Clin Chem, 51, A-28. Suppl 6.
5. Apple, FS, MM Murakami, R Ler, D Walker, and M York (2007). Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dog and monkeys subjected to acute myocardial injury. Clin Chem, 53, A-11. Suppl S.
6. Burgener, IA, A Kovacevic, GN Mauldin, and CW Lombard (2006). Cardiac troponins as indicators of acute myocardial damage in dogs. J Vet Intern Med, 20, 277-83.
7. Feng, X, P Taggart, L Hall, S Bryant, J Sansone, M Kemmerer, J Herlich, and P Lord (2005). Limited additional release of cardiac troponin I and T in isoproterenol-treated beagle dogs with cardiac injury. Clin Chem, 51, 1305-7.
8. Gaze, DC, and PO Collinson (2005). Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection. Expert Opin Drug Metab Toxicol, 1, 715-25.
9. Hemalatha, T, VV Mala, BM Manohar, M Nayeem, S Subramaniam, and R Puvanakrishnan (2006). Studies on biochemical markers in cryoinfarction in rats. Cryo Letters, 27, 311-18.
10. Herman, E, J Zhang, A Knapton, SE Lipshultz, N Rifai, and F Sistare (2006). Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats. Cardiovasc Toxicol, 6, 211-22.
11. Higgins, M, BR Berridge, BJ Mills, AE Schultze, H Gao, GH Searfoss, TK Baker, and TP Ryan (2003). Gene expression analysis of the acute phase response using a canine microarray. Toxicol Sci, 74, 470-84.
12. Kurata, M, T Iidaka, Y Sasayama, T Fukushima, M Sakimura, and N Shirai (2007). Correlation among clinicopathological parameters of myocardial damage in rats treated with isoproterenol. Exp Anim, 56, 57-62.
13. O'Brien, PJ (2006). Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev Mol Diagn, 6, 685-702.
14. O'Brien, PJ, DE Smith, TJ Knechtel, MA Marchak, I Pruimboom-Brees, DJ Brees, DP Spratt, FJ Archer, P Butler, AN Potter, JP Provost, J Richard, PA Snyder, and WJ Reagan (2006). Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim, 40, 153-71.
15. Peetz, D, R Schweigert, N Jachmann, F Post, H Schinzel, and KJ Lackner (2006). Method comparison of cardiac marker assays on PATH-FAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader. Clin Lab, 52, 605-14.
16. Pettit, S, M York, DB Walker, F Apple, E Herman, S Brady, J Turton, B Berridge, R Nicklaus, P Clements, I Mikaelian, and HESI Biomarkers Committee, Cardiac Troponins Expert Working Group (2007). Comparison of commercial cardiac troponin (cTn) assays for evaluation of myocardial injury in the laboratory rat, dog, and Cynomolgus and Rhesus monkey, and kinetic properties of serum cTn in rats with acute cardiotoxicity. The Toxicologist, 48. [CD ROM].
17. Schultze, A, WE Alborn, RK Newton, and RJ Konrad (2005). Administration of a PPAR alpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio. J Lipid Res, 46, 1591-95.
18. Schultze, A, and JM Sullivan (2007). Screening a novel class of anticoagulants for multi-organ toxicity using Fischer 344 rats: involvement of clinical and anatomic pathologists in the early drug development process. Vet Clin Pathol, 36, 123-36.
19. Storti, S, C Prontera, MS Parri, A Iervasi, S Vittorini, M Emdin, GC Zucchelli, G Longombardo, P Migliorini, and A Clerico (2006). Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. Clin Chem Lab Med, 44, 1022-29.
20. Todd, J, B Freese, A Lu, D Held, J Morey, R Livingston, and P Goix (2007). Ultra-sensitive Femtogram Level Flow-based Immunoassays Using Single Molecule Counting Clinical Chemistry. Clin Chem, 53, 1990-95.
21. Wu, A, N Fukushima, R Puskas, J Todd, and P Goix (2006). Development and preliminary clinical validation of a high sensitive assay for cardiac troponin using capillary flow (single molecule) fluorescence detection. Clin. Chem, 52, 2157-58.